Clearmind Medicine Inc.

1.36
-0.01 (-0.73%)
At close: Jan 30, 2025, 3:59 PM
1.40
2.82%
After-hours Jan 30, 2025, 07:38 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -5.25M -6.23M -9.41M -3.90M -233.22K -105.28K -194.53K -6.67K
Depreciation & Amortization 51.07K 41.59K 113.38K 2.57K 179.69 n/a n/a n/a
Stock-Based Compensation 883.87K 366.40K 887.30K 500.24K n/a n/a 147.30K n/a
Other Working Capital -195.06K -253.23K 441.42K -317.61K -23.79K 37.18K -4.93K -2.08K
Other Non-Cash Items -512.70K 210.72K 836.94K 189.69K 28.00 -5.35K -60.00K 371.00
Deferred Income Tax 103.88K 17.37K 40.75K n/a n/a n/a n/a n/a
Change in Working Capital -130.11K -703.89K 1.69M 25.99K -31.23K 42.28K 1.65K -2.45K
Operating Cash Flow -4.86M -6.30M -5.08M -2.84M -264.45K -63.01K -105.59K -9.12K
Capital Expenditures n/a n/a -7.59K -231.19K -10.00K -10.00K -131.17K -18.42K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments -350.40K n/a n/a -20.00K n/a n/a n/a n/a
Sales Maturities Of Investments 78.50K n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies 33.80K -26.23K -7.59M -14.65K 4.91K n/a n/a n/a
Investing Cash Flow -238.10K -26.23K -7.59K -251.19K -5.09K -10.00K -131.17K -18.42K
Debt Repayment -42.59K -40.92K -96.54 n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 4.10M 438.01K 697.98M n/a -448.79K n/a -1.52K 130.00K
Financial Cash Flow 6.25M 8.43M 698.40K 7.36M 598.70K n/a 208.00K 130.00K
Net Cash Flow 1.15M 3.83M -4.42M 4.29M 329.15K -73.01K -28.76K 102.45K
Free Cash Flow -4.86M -6.30M -5.09M -3.07M -274.45K -73.01K -236.76K -27.55K